Quantcast
Last updated on April 16, 2014 at 7:57 EDT

Latest Aspirin Stories

2013-09-02 19:12:32

French analysis of more than 15,000 patients showed that women were undertreated with antithrombotic medications compared to men regardless of their stroke risk and comorbidities General practitioners (GPs) undertreat women with atrial fibrillation (AF), according to research presented at ESC Congress 2013 today by Dr Pierre Sabouret from France. The analysis of more than 15,000 patients showed that women were undertreated with antithrombotic medications compared to men regardless of their...

2013-09-02 10:16:37

The findings were presented at the ESC Congress today by Ms Stina Jakobsson from Sweden. They reveal that reperfusion therapy and secondary prevention drugs produced the decline and brought stroke risk after AMI closer to that of non-diabetics. Ms Jakobsson said: "Ischemic stroke following an acute myocardial infarction is a fairly uncommon but devastating event with high mortality. It has long been recognized that patients with diabetes mellitus are at a particularly high risk of...

2013-08-30 08:25:17

PISCATAWAY, N.J. and SAN DIEGO, Aug. 30, 2013 /PRNewswire/ -- ITC Nexus Holding Company (ITC), a global leader in hemostasis management and Point-of-Care (POC) testing, today announced it has acquired Accumetrics, a global leader in assessing patient response to all major antiplatelet therapies. Terms of the transaction were not disclosed. ITC develops, manufactures, and markets the Hemochron(®) product line, a market-leading POC system used to measure clotting activity for patients...

2013-08-22 08:26:44

MISSISSAUGA, ON, Aug. 22, 2013 /PRNewswire/ - Nuvo Research Inc. (Nuvo) (TSX:NRI), a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10 today announced that its U.S. licensee for PENNSAID(® )(diclofenac sodium topical solution) 1.5% w/w and PENNSAID 2% (diclofenac sodium topical solution) 2% w/w, Mallinckrodt (NYSE:MNK) has advised that the U.S. Food and...

2013-08-15 08:28:27

MISSISSAUGA, ON, Aug. 15, 2013 /PRNewswire/ - Nuvo Research Inc. (Nuvo) (TSX:NRI), a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10 today announced that its U.S. licensing partner for PENNSAID(® )(diclofenac sodium topical solution) 1.5% w/w and PENNSAID 2% (diclofenac sodium topical solution) 2% w/w, Mallinckrodt (NYSE:MNK) has submitted the results...

2013-08-13 23:27:26

Stop The Ringing is an informative tinnitus treatment created by Geoff Barker, who promises to help tinnitus sufferers get rid of ringing in the ear quickly and naturally. A full Stop The Ringing overview on the Vkool.com site points out if the e-book is worth buying. Seattle, Wa (PRWEB) August 13, 2013 Stop The Ringing developed by Geoff Barker is a new book that covers an efficient tinnitus treatment and tips for preventing tinnitus from reoccurring with ease. This program teaches...

2013-07-26 18:38:55

Study finds that high platelet reactivity on clopidogrel predicts stent thrombosis, heart attack, and bleeding but is not directly linked to death Patients who receive a drug-eluting stent (DES) and demonstrate high platelet reactivity on clopidogrel are more likely to have blood clots form on the stent and to suffer a heart attack; however, these patients are less likely to develop bleeding complications. One-year results of the ADAPT-DES trial will be published online July 26, 2013, in...

2013-07-23 23:00:09

Glenn Parris’ “The Renaissance of Aspirin” treats readers to intrigue and adventure. Georgia (PRWEB) July 24, 2013 When Dr. Jonas Salk invented the vaccine to poliomyelitis, he refused to patent it, and instead, he gave the cure away for free, refusing to make monetary gains from his creation due to his desire to better the world by ridding it of a debilitating disease. Unfortunately, similar acts of magnanimity are few and far between in the modern, corporate-dominated world, where...

2013-07-23 08:30:16

MISSISSAUGA, ON, July 23, 2013 /PRNewswire/ - Nuvo Research Inc. (Nuvo) (TSX: NRI), a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain announced today that its U.S. licensing partner, Mallinckrodt, (NYSE:MNK) has successfully completed a pharmacokinetic (PK) study comparing diclofenac sodium topical solution, 2% w/w (PENNSAID 2%) to original PENNSAID.  On March 4, 2013, Mallinckrodt received a Complete Response...

2013-07-22 23:22:07

Adaptrin®, Released A Statement Today Explaining How Its All Natural, Scientifically Proven, Tibetan Herbal Supplement Formula Acts Much Like Baby Aspirin in support of Cardiovascular Health. While baby aspirin is advised for cardiovascular health, Adaptrin® can offer additional benefits that go beyond aspirin’s properties. Staten Island, New York (PRWEB) July 22, 2013 Adaptrin®, Released A Statement Today Explaining How Its All Natural, Scientifically Proven, Tibetan...